Clinical Trial Update: Minocycline as Adjunctive Treatment for Treatment Resistant Depression [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating minocycline as an adjunctive treatment for treatment-resistant depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Treatment Resistant Depression | Phase 3 | Status: COMPLETED